{"id":147,"date":"2025-06-18T14:19:40","date_gmt":"2025-06-18T14:19:40","guid":{"rendered":"https:\/\/acinolatam.com\/news\/"},"modified":"2026-04-10T11:29:42","modified_gmt":"2026-04-10T11:29:42","slug":"news","status":"publish","type":"page","link":"https:\/\/acinolatam.com\/pt-br\/news\/","title":{"rendered":"News"},"content":{"rendered":"<div id=\"news-archive-0\" class=\"news-archive acino-grid--first\" data-view=\"news-archive\"><div class=\"container article-container\"><article><a href=\"https:\/\/acinolatam.com\/pt-br\/news\/article\/market-announcement-nabota-packaging-update\" class=\"block-link\"><strong class=\"text\">25.05.2026<\/strong><h2>Comunicado ao Mercado. Atualiza\u00e7\u00e3o de embalagem do produto NABOTA\u00ae<\/h2><p class=\"text\">A Moksha8 Brasil Ind\u00fastria e Com\u00e9rcio de Medicamentos Ltda. (\u201cM8\u201d), respons\u00e1vel pela importa\u00e7\u00e3o e comercializa\u00e7\u00e3o exclusiva do produto NABOTA\u00ae (toxina&#8230;<\/p><\/a><\/article><article><a href=\"https:\/\/acinolatam.com\/pt-br\/news\/article\/comunicado-por-robo-de-medicamento-23-de-marzo-2025\" class=\"block-link\"><strong class=\"text\">11.03.2026<\/strong><h2>Comunicado sobre o roubo de medicamentos 23 de mar\u00e7o de 2025<\/h2><p class=\"text\">Prezados clientes e profissionais da \u00e1rea da sa\u00fade, nossa principal prioridade \u00e9 garantir a qualidade, a efic\u00e1cia e a seguran\u00e7a&#8230;<\/p><\/a><\/article><article><a href=\"https:\/\/acinolatam.com\/pt-br\/news\/article\/notice-regarding-theft-of-medication-may-18-2025\" class=\"block-link\"><strong class=\"text\">11.03.2026<\/strong><h2>Aviso sobre Roubo de Medicamentos 18 de maio de 2025<\/h2><p class=\"text\">Prezados clientes e profissionais da \u00e1rea da sa\u00fade, nossa principal prioridade \u00e9 garantir a qualidade, a efic\u00e1cia e a seguran\u00e7a&#8230;<\/p><\/a><\/article><article><a href=\"https:\/\/acinolatam.com\/pt-br\/news\/article\/comunicado-de-descontinuacao-temporaria-de-importacao-para-os-medicamentos-haldol-haloperidol-e-haldol-decanoato-decanoato-de-haloperidol\" class=\"block-link\"><strong class=\"text\">05.02.2026<\/strong><h2>Comunicado de Descontinua\u00e7\u00e3o Tempor\u00e1ria de Importa\u00e7\u00e3o para os Medicamentos Haldol (haloperidol) e Hadol Decanoato (decanoato de haloperidol)<\/h2><p class=\"text\">Em conformidade com a Resolu\u00e7\u00e3o RDC n\u00ba 18\/2014, estabelecida pela Anvisa (Ag\u00eancia Nacional de Vigil\u00e2ncia Sanit\u00e1ria), a empresa Moksha8 Brasil&#8230;<\/p><\/a><\/article><article><a href=\"https:\/\/acinolatam.com\/pt-br\/news\/article\/report-on-transparency-and-pay-equity-between-women-and-men\" class=\"block-link\"><strong class=\"text\">31.12.2025<\/strong><h2>Relat\u00f3rio de Transpar\u00eancia e Igualdade Salarial de Mulheres e Homens<\/h2><p class=\"text\"><\/p><\/a><\/article><article><a href=\"https:\/\/acinolatam.com\/pt-br\/news\/article\/notice-of-registration-cancellation-for-the-drug-ultraproct-ldo-fluocortolone-pivalate-lidocaine-hydrochloride\" class=\"block-link\"><strong class=\"text\">13.11.2025<\/strong><h2>Comunicado de Cancelamento de Registro para o Medicamento Ultraproct LDO (pivalato de fluocortolona, cloridrato de lidoca\u00edna)<\/h2><p class=\"text\">Em conformidade com a Resolu\u00e7\u00e3o RDC n\u00ba 18\/2014, estabelecida pela Anvisa (Ag\u00eancia Nacional de Vigil\u00e2ncia Sanit\u00e1ria), a empresa Moksha8 Brasil&#8230;<\/p><\/a><\/article><article><a href=\"https:\/\/acinolatam.com\/pt-br\/news\/article\/cargo-theft-alert-nabota-100u-lot-x25025\" class=\"block-link\"><strong class=\"text\">02.09.2025<\/strong><h2>Alerta sobre roubo de carga: NABOTA\u00ae 100U \u2013 lote X25025<\/h2><p class=\"text\"><\/p><\/a><\/article><article><a href=\"https:\/\/acinolatam.com\/pt-br\/news\/article\/notice-of-lisodrens-registration-cancellation\" class=\"block-link\"><strong class=\"text\">06.01.2025<\/strong><h2>Comunicado de cancelamento de registro do Lisodren<\/h2><p class=\"text\">A Moksha8 Brasil Ind\u00fastria e Com\u00e9rcio de Medicamentos Ltda (\u201cM8 Pharmaceuticals\u201d) informa que em 07 de maio de 2024, solicitou&#8230;<\/p><\/a><\/article><article><a href=\"https:\/\/acinolatam.com\/pt-br\/news\/article\/leadership-announcements-and-new-arcera-structure\" class=\"block-link\"><strong class=\"text\">02.12.2024<\/strong><h2>Leadership Announcements and New Arcera Structure<\/h2><p class=\"text\">Arcera aims to become a global life sciences company, with the purpose of enabling longer and healthier lives while driving&#8230;<\/p><\/a><\/article><\/div><div class=\"container button-container\"><button class=\"button accentFour-border load-more\" data-cat=\"18\" data-page=\"1\" data-max-pages=\"3\">Load More<\/button><\/div><\/div>","protected":false},"excerpt":{"rendered":"","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"templates\/news-archive.php","meta":{"_acf_changed":false,"footnotes":""},"class_list":["post-147","page","type-page","status-publish","hentry"],"acf":[],"_links":{"self":[{"href":"https:\/\/acinolatam.com\/pt-br\/wp-json\/wp\/v2\/pages\/147","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/acinolatam.com\/pt-br\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/acinolatam.com\/pt-br\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/acinolatam.com\/pt-br\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/acinolatam.com\/pt-br\/wp-json\/wp\/v2\/comments?post=147"}],"version-history":[{"count":6,"href":"https:\/\/acinolatam.com\/pt-br\/wp-json\/wp\/v2\/pages\/147\/revisions"}],"predecessor-version":[{"id":2006,"href":"https:\/\/acinolatam.com\/pt-br\/wp-json\/wp\/v2\/pages\/147\/revisions\/2006"}],"wp:attachment":[{"href":"https:\/\/acinolatam.com\/pt-br\/wp-json\/wp\/v2\/media?parent=147"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}